SEC Form 4 · accession 0000899243-19-007526
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Orford
Officer — Chief Medical Officer
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 11, 2019 | S | 1,565 | $6.00 | D | 11,249 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
- F2Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018.